Zebra Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,465
Closed -$251K 403
2018
Q3
$251K Buy
+1,465
New +$251K 0.11% 339